Original language | English |
---|---|
Journal | Default journal |
Publication status | Published - 1998 Jun 13 |
Cite this
Eckel, J., Hideho, TANAKA., Liu, ISHII. S., & Tanaka, H. (1998). The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis. Default journal.
The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis. / Eckel, Jurgen; Hideho, TANAKA; Liu, ISHII ShinichiLisen; Tanaka, Hideho.
In: Default journal, 13.06.1998.Research output: Contribution to journal › Article
Eckel, J, Hideho, TANAKA, Liu, ISHIIS & Tanaka, H 1998, 'The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis', Default journal.
Eckel J, Hideho TANAKA, Liu ISHIIS, Tanaka H. The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis. Default journal. 1998 Jun 13.
@article{75d8953725b6409ca1b786672490dd8a,
title = "The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis",
author = "Jurgen Eckel and TANAKA Hideho and Liu, {ISHII ShinichiLisen} and Hideho Tanaka",
year = "1998",
month = "6",
day = "13",
language = "English",
journal = "Default journal",
}
TY - JOUR
T1 - The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis
AU - Eckel, Jurgen
AU - Hideho, TANAKA
AU - Liu, ISHII ShinichiLisen
AU - Tanaka, Hideho
PY - 1998/6/13
Y1 - 1998/6/13
M3 - Article
JO - Default journal
JF - Default journal
ER -